Chow, Z., Johnson, J., Chauhan, A., Izumi, T., Cavnar, M., Weiss, H., . . . Rychahou, P. (2021). PI3K/mTOR Dual Inhibitor PF-04691502 Is a Schedule-Dependent Radiosensitizer for Gastroenteropancreatic Neuroendocrine Tumors. Cells.
Style de citation ChicagoChow, Zeta, et al. "PI3K/mTOR Dual Inhibitor PF-04691502 Is a Schedule-Dependent Radiosensitizer for Gastroenteropancreatic Neuroendocrine Tumors." Cells 2021.
Style de citation MLAChow, Zeta, et al. "PI3K/mTOR Dual Inhibitor PF-04691502 Is a Schedule-Dependent Radiosensitizer for Gastroenteropancreatic Neuroendocrine Tumors." Cells 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.